Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 09/06/20081 min de lecture
Notice of Approval of Supplemental New Animal Drug Application; Moxidectin
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is providing notice that it has approved a supplemental new animal drug application (NADA) filed by Fort Dodge Animal Health, Division of Wyeth. The approved NADA provides for the veterinary prescription use of a sustained-release injectable moxidectin formulation for prevention of heartworm disease and treatment of existing hookworm infections in dogs. The supplemental NADA adds animal safety information to product labeling.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →